Crfg-1a, a target and marker for chronic renal failure
CA 2236248 A1 · Owner: Smithkline Beecham Corporation · Inventors: Olson, Barbara; Laping, Nicholas J.; Zhu, Yuan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
CRFG-la polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CRFG-la polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal disease, renal ischemia diabetic nephropathy acute renal failure, Neurodegenerative disease and, Alzheimer's disease, among others and diagnostic assays for such conditions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 29, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 29, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 29, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.